Nine Square Therapeutics Corp

Alumis provides precision medicines. They transform the lives of patients with autoimmune diseases. They bring a proven track record in precision drug development of groundbreaking therapies. They rewrite the autoimmune treatment playbook with a unique precision analytics platform to advancing their understanding of immunologic diseases. They build a pipeline of therapeutics based on genetically validated targets for application in the treatment of multiple autoimmune disease indications.

Gordian Biotechnology, located in South San Francisco, is dedicated to discovering new therapies for complex age-related diseases through its proprietary in vivo drug discovery platform. By utilizing innovative methods such as Patient Avatars and Mosaic Screening, the company aims to identify targets and therapies that are most likely to succeed in human trials. With a mission to enhance the quality of life for individuals facing age-related challenges, Gordian's Pythia approach examines the entire transcriptome to assess the effects of various therapies on cellular pathways. Led by CEO Francisco LePort, the company is committed to enabling people to lead longer, healthier lives. Generated from the website

Sonoma Biotherapeutics, located in South San Francisco, is dedicated to developing innovative living cell therapies aimed at restoring balance to the immune system and curing autoimmune and inflammatory diseases. The company builds upon decades of research and is pioneering advancements in Treg biology and cell therapy, focusing on transforming the lives of patients affected by these conditions. With a strong emphasis on scientific validation, Sonoma Biotherapeutics is actively conducting clinical trials for several of its product candidates. The organization is distinguished by its collaborative approach, effectively merging academic expertise with practical execution to address both sides of immune balance. Generated from the website